SNYR
NasdaqSynergy CHC Corp.
Basic Materials · Medicinal Chemicals & Botanical Products
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$33.8M
2018
$29.4M
2019
$42.8M
2023
$34.8M
2024
$30.4M
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$30.4M
Net Income$-12.3M
Gross Profit$20.3M
Oper Income$-8.5M
EPS (dil)$-1.27
Rev/sh$2.04
FCF/sh$-0.18
Book/sh$-1.55
Gross M66.8%
Oper M-27.8%
Profit M-40.6%
FCF M-8.9%
ROE53.4%
ROA-121.4%
ROIC-261.2%
R&D/Rev—
Rev Y/Y-12.8%
Rev 3Y CAGR1.1%
EPS Y/Y-553.6%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout-10%
Div/sh—
Shs Chg Y/Y+27.4%
Current Ratio1.22
Quick Ratio0.76
Debt/Eq-1.26
Int Coverage-1.4×
Net Debt$26.3M
Total Debt$29.1M
Cash & Eq$2.7M
Total Assets$10.2M
Oper CF$-2.6M
Capex$129,087
Free CF$-2.7M
Buybacks—
Equity$-23.1M
Liabilities$33.3M
Shs Outstand0.01B
SectorBasic Materials
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2018 | FY2019 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $33.8M | $29.4M | $42.8M | $34.8M | $30.4M |
| Gross Profit | $22.8M | $20.2M | $32.1M | $23.6M | $20.3M |
| Operating Income | $-4.9M | $-8.0M | $10.8M | $5.8M | $-8.5M |
| Net Income | $-6.2M | $-9.2M | $6.3M | $2.1M | $-12.3M |
| Diluted EPS | $-0.07 | $-0.10 | $0.86 | $0.28 | $-1.27 |
| Operating Cash Flow | $1.3M | $2.9M | $421,729 | $-4.8M | $-2.6M |
| Free Cash Flow | $1.2M | — | — | — | — |
COMMUNITY · $SNYR0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.